Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

doi:10.1002/hep.31646

Review

. 2021 Jan;73(1):366-413.

doi: 10.1002/hep.31646. Epub 2021 Jan 20.

Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

Patrick G Northup¹, Juan Carlos Garcia-Pagan^{2

3

4}, Guadalupe Garcia-Tsao^{5

6}, Nicolas M Intagliata¹, Riccardo A Superina⁷, Lara N Roberts⁸, Ton Lisman⁹, Dominique C Valla^{10

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, Center for the Study of Hemostasis in Liver Disease, University of Virginia, Charlottesville, VA.
² Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
⁴ Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver), Barcelona, Spain.
⁵ Department of Internal Medicine, Section of Digestive Diseases, Yale University, New Haven, CT.
⁶ Veterans Administration Healthcare System, West Haven, CT.
⁷ Department of Transplant Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
⁸ Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom.
⁹ Section of Hepatobiliary Surgery and Liver Transplantation, Surgical Research Laboratory, Department of Surgery, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
¹⁰ Hepatology Service, Hospital Beaujon, Clichy, France.

PMID: 33219529
DOI: 10.1002/hep.31646

Review

Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

Patrick G Northup et al. Hepatology. 2021 Jan.

. 2021 Jan;73(1):366-413.

doi: 10.1002/hep.31646. Epub 2021 Jan 20.

Authors

Patrick G Northup¹, Juan Carlos Garcia-Pagan^{2

3

4}, Guadalupe Garcia-Tsao^{5

6}, Nicolas M Intagliata¹, Riccardo A Superina⁷, Lara N Roberts⁸, Ton Lisman⁹, Dominique C Valla^{10

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, Center for the Study of Hemostasis in Liver Disease, University of Virginia, Charlottesville, VA.
² Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
⁴ Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver), Barcelona, Spain.
⁵ Department of Internal Medicine, Section of Digestive Diseases, Yale University, New Haven, CT.
⁶ Veterans Administration Healthcare System, West Haven, CT.
⁷ Department of Transplant Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
⁸ Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom.
⁹ Section of Hepatobiliary Surgery and Liver Transplantation, Surgical Research Laboratory, Department of Surgery, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
¹⁰ Hepatology Service, Hospital Beaujon, Clichy, France.

PMID: 33219529
DOI: 10.1002/hep.31646

No abstract available

PubMed Disclaimer

Comment in

Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases.
Fortea JI, Puente Á, Crespo J, Fábrega E. Fortea JI, et al. Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):105-109. doi: 10.21037/hbsn-22-556. Epub 2023 Jan 16. Hepatobiliary Surg Nutr. 2023. PMID: 36860261 Free PMC article. No abstract available.

Cited by

Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures.
Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U. Gallo P, et al. World J Gastroenterol. 2022 Aug 14;28(30):4061-4074. doi: 10.3748/wjg.v28.i30.4061. World J Gastroenterol. 2022. PMID: 36157107 Free PMC article. Review.
Portal vein thrombosis risk factors in liver transplant candidates.
Ak C, Adali G, Sayar S, Agackiran A, Kulali F, Kahraman R, Ozturk O, Ozdil K. Ak C, et al. Hepatol Forum. 2022 Sep 23;3(3):88-92. doi: 10.14744/hf.2022.2022.0005. eCollection 2022 Sep. Hepatol Forum. 2022. PMID: 36177096 Free PMC article.
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
Chun HS, Choe AR, Lee M, Cho Y, Kim HY, Yoo K, Kim TH. Chun HS, et al. Clin Mol Hepatol. 2021 Oct;27(4):535-552. doi: 10.3350/cmh.2021.0109. Epub 2021 Jun 16. Clin Mol Hepatol. 2021. PMID: 34130370 Free PMC article. Review.
Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation.
Sebagh M, Yilmaz F, Kounis I, Saliba F, Feray C, Taupin JL, Cherqui D, Azoulay D, Samuel D, Coilly A, Demetris AJ, Neil D. Sebagh M, et al. Transpl Int. 2023 Jul 26;36:11306. doi: 10.3389/ti.2023.11306. eCollection 2023. Transpl Int. 2023. PMID: 37565050 Free PMC article.
[Efficacy Evaluation of Three Endoscopic Therapies of Isolated Gastric Varices with Modified Tissue Adhesive].
Ai ZL, Min M, Hu JL, Liang XX, Zhou YL, Ma JL, Jiang Y, He LL, Li P. Ai ZL, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 May;53(3):386-390. doi: 10.12182/20220560102. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35642143 Free PMC article. Chinese.

See all "Cited by" articles

References

1. DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009;49:1729-1764.
1. European Association for the Study of the Liver Diseases. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol 2016;64:179-202.
1. Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol 2020;115:18-40.
1. Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost 2017;1:150-161.
1. Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-1427.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

[1] DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009;49:1729-1764.

[2] DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009;49:1729-1764.

[3] European Association for the Study of the Liver Diseases. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol 2016;64:179-202.

[4] European Association for the Study of the Liver Diseases. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol 2016;64:179-202.

[5] Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol 2020;115:18-40.

[6] Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol 2020;115:18-40.

[7] Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost 2017;1:150-161.

[8] Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost 2017;1:150-161.

[9] Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-1427.

[10] Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-1427.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

Affiliations

Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical